<?xml version="1.0"?>
<presentation title="Ichiro Yasuda" width="720.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{30D69993-F706-4C40-9DC6-EC8593B79689}">
	<presenters>
		<presenter name="Ichiro Yasuda, MD, PhD." title="Department of Gastroenterology, Teikyo University Mizonokuchi Hospital,Kawasaki, Japan" email="" web="" phone="" photoAssetId="">
			<bio>EUS-guided CPN/CGN:
Technique, efficacy and complications</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets/>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<videoTracks>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21711267" width="240" height="180">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="31.6700000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21713155" width="240" height="180">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="44.2999992"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21714746" width="240" height="180">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="33.2039986"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21715916" width="240" height="180">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="24.4729996"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21717148" width="240" height="180">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="23.3589993"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21719738" width="240" height="180">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="58.6069984"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21723076" width="240" height="180">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="84.8450000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21724356" width="240" height="180">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="27.9099998"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21728178" width="240" height="180">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="88.5599976"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21729597" width="240" height="180">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="30.7399998"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586810.spr0_21730845" width="240" height="180">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="19.8759995"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586810.spr0_21732031" width="240" height="180">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="24.3460000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586810.spr0_21733326" width="240" height="180">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="18.9470000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586810.spr0_21734355" width="240" height="180">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="21.3619995"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21735244" width="240" height="180">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="15.3699999"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_1d586650.spr0_21736430" width="240" height="180">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="22.1000000"/>
			</videoTrack>
		</videoTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="true"/>
					<button type="presenterInfo" visible="true"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>false</showPresenterInfo>
				<showPresenterVideo>true</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>true</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="never"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="EUS-guided CPN/CGN: Technique, efficacy and complications" titleNormalized="eus-guided cpn/cgn: technique, efficacy and complications" src="slide1.swf" size="66286" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="31.6690001"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided CPN/CGN:
Technique, efficacy and complications
Ichiro Yasuda, MD, PhD.
Department of Gastroenterology, 
Teikyo University Mizonokuchi Hospital,
Kawasaki, Japan</text>
		</slide>
		<slide index="1" title="Basic Theory of Celiac Plexus Neurolysis" titleNormalized="basic theory of celiac plexus neurolysis" src="slide2.swf" size="37994" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="44.2989992"/>
			</animationSteps>
			<notes>The celiac plexus surrounds the celiac artery and the superior mesenteric artery, and it consists of several ganglia and connecting neural rami.
It transmits pain sensations from the upper abdominal organs such as the pancreas, liver, gallbladder, stomach, and ascending colon.
The celiac plexus neurolysis (CPN) is used to disrupt the transmission of such pain signals by injecting neurolytic agent into the celiac plexus.</notes>
			<notesNormalized>the celiac plexus surrounds the celiac artery and the superior mesenteric artery, and it consists of several ganglia and connecting neural rami.
it transmits pain sensations from the upper abdominal organs such as the pancreas, liver, gallbladder, stomach, and ascending colon.
the celiac plexus neurolysis (cpn) is used to disrupt the transmission of such pain signals by injecting neurolytic agent into the celiac plexus.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The celiac plexus surrounds the celiac artery and the superior mesenteric artery, and it consists of several ganglia and connecting neural rami.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;It transmits pain sensations from the upper abdominal organs such as the pancreas, liver, gallbladder, stomach, and ascending colon.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The celiac plexus neurolysis (CPN) is used to disrupt the transmission of such pain signals by injecting neurolytic agent into the celiac plexus.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Celiac artery (CA)
Ganglion
Ganglion
Ganglion
Superior mesenteric artery
(SMA)
Rt.- greater splanchnic nerve
Lt.- greater splanchnic nerve
2
 The CPN is used to disrupt the transmission of pain signals from the afferent nerves to the spinal cord by injecting neurolytic agent into the celiac plexus.
Basic Theory of Celiac Plexus Neurolysis</text>
		</slide>
		<slide index="2" title="Various approaches for CPN" titleNormalized="various approaches for cpn" src="slide3.swf" size="3006" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="33.2029986"/>
			</animationSteps>
			<notes>The celiac plexus neurolysis was initially described as an intraoperative technique by Kappis in 1914.
Since then, it has been performed under radiographic, fluoroscopic, CT, or ultrasonographic guidance.
In addition, EUS-guided technique was recently introduced by Wiersema. </notes>
			<notesNormalized>the celiac plexus neurolysis was initially described as an intraoperative technique by kappis in 1914.
since then, it has been performed under radiographic, fluoroscopic, ct, or ultrasonographic guidance.
in addition, eus-guided technique was recently introduced by wiersema.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The celiac plexus neurolysis was initially described as an intraoperative technique by Kappis in 1914.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Since then, it has been performed under radiographic, fluoroscopic, CT, or ultrasonographic guidance.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In addition, EUS-guided technique was recently introduced by Wiersema. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Kappis M (1914): Intraoperative
 Radiographic
 Fluoroscopic
 CT-guided
 US-guided 
 Wiersema MJ (1996): EUS-guided
Various approaches for CPN
3</text>
		</slide>
		<slide index="3" title="Indications of CPN" titleNormalized="indications of cpn" src="slide4.swf" size="2363" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.4719996"/>
			</animationSteps>
			<notes>The indications of CPN is pain originated from the upper abdominal organs.
The most major indication of this procedure is pancreatic cancer pain, because pain is a common symptom reported by 90% of patients with advanced pancreatic cancer, and it represents a major issue in the management of the patients.
Pain due to chronic pancreatitis is also indicated.</notes>
			<notesNormalized>the indications of cpn is pain originated from the upper abdominal organs.
the most major indication of this procedure is pancreatic cancer pain, because pain is a common symptom reported by 90% of patients with advanced pancreatic cancer, and it represents a major issue in the management of the patients.
pain due to chronic pancreatitis is also indicated.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The indications of CPN is pain originated from the upper abdominal organs.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The most major indication of this procedure is pancreatic cancer pain, because pain is a common symptom reported by 90% of patients with advanced pancreatic cancer, and it represents a major issue in the management of the patients.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Pain due to chronic pancreatitis is also indicated.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Indications of CPN
4
 Upper abdominal cancer pain
Pancreatic cancer, Biliary cancer, Gastric cancer, ….
 Chronic pancreatitis
Pain is a common symptom reported by 90% of patients with 
 advanced pancreatic cancer.
(Caraceni A. Cancer 1996)
Pain originated from the upper abdominal organs</text>
		</slide>
		<slide index="4" title="Techniques of EUS-CPN" titleNormalized="techniques of eus-cpn" src="slide5.swf" size="256776" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="23.3579993"/>
			</animationSteps>
			<notes>Two techniques are used for EUS-CPN.
One is the central technique. 
In this technique, a neurolytic agent is injected at the base of the celiac axis.
Another technique is the bilateral technique.  In this technique, a neurolytic agent is injected on both sides of the celiac axis.</notes>
			<notesNormalized>two techniques are used for eus-cpn.
one is the central technique. 
in this technique, a neurolytic agent is injected at the base of the celiac axis.
another technique is the bilateral technique. in this technique, a neurolytic agent is injected on both sides of the celiac axis.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Two techniques are used for EUS-CPN.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;One is the central technique. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In this technique, a neurolytic agent is injected at the base of the celiac axis.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Another technique is the bilateral technique.  In this technique, a neurolytic agent is injected on both sides of the celiac axis.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Techniques of EUS-CPN
 Central technique
 Bilateral technique
5
The neurolytic agent is injected at the base or on both sides of the celiac axis.
CA
Ao
SMA
needle
(probable location of the celiac ganglia)</text>
		</slide>
		<slide index="5" title="EUS-CPN (Central technique)" titleNormalized="eus-cpn (central technique)" src="slide6.swf" size="123022" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video0" videoClipId="ispring.resources_1d6642a0.spr0_21579680" slides="1" repeat="1" volume="0.0000000" posterFrameId="ispring.resources_1d6642a0.spr2_21579680" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<pauseVideo frameIndex="0" videoId="video0"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="58.6059984"/>
			</animationSteps>
			<notes>First, I will show the video clip of the central technique.
After the abdominal aorta is visualized in the longitudinal plane on the EUS image, the aorta is traced to identify the CA. Subsequently, a needle is advanced to a point just above the point where the CA originates from the aorta. 
Absolute ethanol is injected into the region until the echogenic cloud widespread sufficiently.</notes>
			<notesNormalized>first, i will show the video clip of the central technique.
after the abdominal aorta is visualized in the longitudinal plane on the eus image, the aorta is traced to identify the ca. subsequently, a needle is advanced to a point just above the point where the ca originates from the aorta. 
absolute ethanol is injected into the region until the echogenic cloud widespread sufficiently.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;First, I will show the video clip of the central technique.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After the abdominal aorta is visualized in the longitudinal plane on the EUS image, the aorta is traced to identify the CA. Subsequently, a needle is advanced to a point just above the point where the CA originates from the aorta. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Absolute ethanol is injected into the region until the echogenic cloud widespread sufficiently.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-CPN (Central technique)
Video 1
6</text>
		</slide>
		<slide index="6" title="EUS-CPN (Bilateral technique)" titleNormalized="eus-cpn (bilateral technique)" src="slide7.swf" size="150943" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video1" videoClipId="ispring.resources_1d666bc0.spr0_21591411" slides="1" repeat="1" volume="0.0000000" posterFrameId="ispring.resources_1d666bc0.spr2_21591411" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<pauseVideo frameIndex="0" videoId="video1"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="84.8440012"/>
			</animationSteps>
			<notes>I will also show the bilateral technique.
After the origin of the CA is identified, the echoendoscope is rotated clockwise until the CA and SMA are no longer visible. 
The needle is then advanced toward the left, alongside the CA and SMA, up to a position lateral to the point where the SMA originates from the aorta. 
Absolute ethanol is injected into this region. 
Next, the echoendoscope is rotated counterclockwise until the CA and SMA are no longer visible. 
The needle is advanced to the right lateral base of the SMA, and absolute ethanol is injected once again. </notes>
			<notesNormalized>i will also show the bilateral technique.
after the origin of the ca is identified, the echoendoscope is rotated clockwise until the ca and sma are no longer visible. 
the needle is then advanced toward the left, alongside the ca and sma, up to a position lateral to the point where the sma originates from the aorta. 
absolute ethanol is injected into this region. 
next, the echoendoscope is rotated counterclockwise until the ca and sma are no longer visible. 
the needle is advanced to the right lateral base of the sma, and absolute ethanol is injected once again.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;I will also show the bilateral technique.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After the origin of the CA is identified, the echoendoscope is rotated clockwise until the CA and SMA are no longer visible. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The needle is then advanced toward the left, alongside the CA and SMA, up to a position lateral to the point where the SMA originates from the aorta. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Absolute ethanol is injected into this region. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Next, the echoendoscope is rotated counterclockwise until the CA and SMA are no longer visible. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The needle is advanced to the right lateral base of the SMA, and absolute ethanol is injected once again. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-CPN (Bilateral technique)
Video 1
7</text>
		</slide>
		<slide index="7" title="EUS-guided direct celiac ganglia neurolysis (EUS-CGN)" titleNormalized="eus-guided direct celiac ganglia neurolysis (eus-cgn)" src="slide8.swf" size="253884" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="27.9089998"/>
			</animationSteps>
			<notes>In addition, another new technique has recently been introduced. 
In this technique, the celiac ganglia is punctured and neurolytic agent is directly injected in it. </notes>
			<notesNormalized>in addition, another new technique has recently been introduced. 
in this technique, the celiac ganglia is punctured and neurolytic agent is directly injected in it.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In addition, another new technique has recently been introduced. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In this technique, the celiac ganglia is punctured and neurolytic agent is directly injected in it. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>8
EUS-guided direct celiac ganglia neurolysis
 (EUS-CGN)
Levy MJ. Am J Gastroenterol 2008, Ascunce G. Gastrointest Endosc 2011, LeBlanc JK, Diagn Ther Endosc 2013,
Doi S. Endoscopy 2013, Ishiwatari H. World J Gastroenterol 2014.</text>
		</slide>
		<slide index="8" title="" titleNormalized="" src="slide9.swf" size="182777" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video2" videoClipId="ispring.resources_1db84ba0.spr0_21700628" slides="1" repeat="1" volume="0.0000000" posterFrameId="ispring.resources_1db84ba0.spr2_21700628" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<pauseVideo frameIndex="0" videoId="video2"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="88.5589976"/>
			</animationSteps>
			<notes>In this case, two celiac ganglia are identified at a site just medial to the left adrenal gland.
A needle puncture was made, and the needle was advanced to the distal end of the lower ganglion.
Thereafter, absolute ethanol was injected.
After the injection, the ganglion became hyperechoic. 
As the needle was withdrawn, ethanol was injected into the ganglion until identification of the ganglion became difficult.
Next, the upper ganglion is punctured, and ethanol is injected.
This procedure was repeated until identification of all ganglia became difficult.</notes>
			<notesNormalized>in this case, two celiac ganglia are identified at a site just medial to the left adrenal gland.
a needle puncture was made, and the needle was advanced to the distal end of the lower ganglion.
thereafter, absolute ethanol was injected.
after the injection, the ganglion became hyperechoic. 
as the needle was withdrawn, ethanol was injected into the ganglion until identification of the ganglion became difficult.
next, the upper ganglion is punctured, and ethanol is injected.
this procedure was repeated until identification of all ganglia became difficult.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In this case, two celiac ganglia are identified at a site just medial to the left adrenal gland.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;A needle puncture was made, and the needle was advanced to the distal end of the lower ganglion.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Thereafter, absolute ethanol was injected.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After the injection, the ganglion became hyperechoic. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;As the needle was withdrawn, ethanol was injected into the ganglion until identification of the ganglion became difficult.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Next, the upper ganglion is punctured, and ethanol is injected.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;This procedure was repeated until identification of all ganglia became difficult.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>9</text>
		</slide>
		<slide index="9" title="Pain relief by EUS-CPN" titleNormalized="pain relief by eus-cpn" src="slide10.swf" size="51207" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="30.7389998"/>
			</animationSteps>
			<notes>Two meta-analysis have previously been published.
They showed that pain relief was achieved in around 73 to 80% of patients with pancreatic cancer pain and in 50-60% of chronic pancreatitis.</notes>
			<notesNormalized>two meta-analysis have previously been published.
they showed that pain relief was achieved in around 73 to 80% of patients with pancreatic cancer pain and in 50-60% of chronic pancreatitis.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Two meta-analysis have previously been published.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;They showed that pain relief was achieved in around 73 to 80% of patients with pancreatic cancer pain and in 50-60% of chronic pancreatitis.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Pain relief by EUS-CPN
10
The pooled proportion of patients with pancreatic cancer that showed pain relief was 80.12% (95% CI = 74.47–85.22). 
In patients with pain due to chronic pancreatitis, EUS-guided CPN provided pain relief in 59.45% (95% CI = 54.51–64.30).
2 meta-analysis
Puli SR. Dig Dis Sci 2009
Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer.
Kaufman M, Singh G, Das S, Concha-Parra R, Erber J, Micames C, Gress F.
Kaufman M. J Clin Gastroenterol 2010
EUS-guided CPN was 72.54% effective in managing pain due to pancreatic cancer and is a reasonable option for patients with tolerance to narcotic analgesics.
EUS-guided CPB was 51.46% effective in managing chronic abdominal pain in patients with chronic pancreatitis.</text>
		</slide>
		<slide index="10" title="Central vs. Bilateral technique" titleNormalized="central vs. bilateral technique" src="slide11.swf" size="4173" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.8749995"/>
			</animationSteps>
			<notes>Some studies have suggested that the bilateral technique was more effective than the central technique.
But it is also true that the central technique is easier and possibly safer than the bilateral technique.</notes>
			<notesNormalized>some studies have suggested that the bilateral technique was more effective than the central technique.
but it is also true that the central technique is easier and possibly safer than the bilateral technique.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Some studies have suggested that the bilateral technique was more effective than the central technique.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;But it is also true that the central technique is easier and possibly safer than the bilateral technique.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Central vs. Bilateral technique
Study design
Central
Bilateral
P
Sahai AV 
(Am J Gastroenterol 2009)
Retrospective
45.9%a
70.4%a
0.0016
Puli SR
(Dig Dis Sci 2009)
Meta-analysis
46.0%b
84.5%b
-
LeBlanc JK 
(Gastrointest Endosc 2011)
Prospective
69%b
81%b
0.340
a mean% of pain reduction, b % of patients with pain relief 
11
Bilateral technique: more effective
Central technique: easier and possibly safer</text>
		</slide>
		<slide index="11" title="EUS-CPN vs. EUS-CGN" titleNormalized="eus-cpn vs. eus-cgn" src="slide12.swf" size="90516" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.3450007"/>
			</animationSteps>
			<notes>Our multicenter RCT showed that EUS–CGN was significantly superior to conventional EUS–CPN (central technique) in cancer pain relief.</notes>
			<notesNormalized>our multicenter rct showed that eus–cgn was significantly superior to conventional eus–cpn (central technique) in cancer pain relief.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Our multicenter RCT showed that EUS–CGN was significantly superior to conventional EUS–CPN (central technique) in cancer pain relief.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-CPN vs. EUS-CGN
12
EUS–CGN was significantly superior to conventional EUS–CPN (central technique) in cancer pain relief.
Doi S, Yasuda I, et al. Endoscopy 2013</text>
		</slide>
		<slide index="12" title="Complications of EUS-CPN" titleNormalized="complications of eus-cpn" src="slide13.swf" size="3639" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.9460005"/>
			</animationSteps>
			<notes>Complications of EUS-CPN included transient pain exacerbation, hypotension, diarrhea, and inebriation sometimes occurs. 
However, most of such complications are not serious.</notes>
			<notesNormalized>complications of eus-cpn included transient pain exacerbation, hypotension, diarrhea, and inebriation sometimes occurs. 
however, most of such complications are not serious.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Complications of EUS-CPN included transient pain exacerbation, hypotension, diarrhea, and inebriation sometimes occurs. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;However, most of such complications are not serious.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Transient pain exacerbation (0-36.0%)
Transient hypotension (0-33.0%)
Transient diarrhea (0-23.4%) 
Inebriation (0-12.5%)
Retroperitoneal hemorrhage (0-1.0%)
Infectious complications (0-1.0%)
GI bleeding (0-2.9%)
Complications of EUS-CPN
13
Wiersema MJ. Gastrointest Endosc 1996, Harada N. Gastrointest Endosc Clin N Am 1997, 
Gress F. Am J Gastroenterol 1999, Gress F. Am J Gastroenterol 2001, 
Gunaratnam NT. Gastrointest Endosc 2001, Sakamoto H. Dig Endosc 2006, 
Levy MJ. Am J Gastroenterol 2008, Sahai AV. Am J Gastroenterol 2009, 
O’Toole TM. Endoscopy 2009, Sakamoto H. Am J Gastroenterol 2010, Iwata K. Dig Endosc 2011, 
LeBlanc JK. Gastrointest Endosc 2011, Ascunce G. Gastrointest Endosc 2011, 
Wiechowska-Kozlowska A. Gastroenterol Res Pract 2012, Seicean A. J Gastrointest Liver Dis 2013, 
LeBlanc JK, Diagn Ther Endosc 2013, Doi S. Endoscopy 2013, 
Tellez-Avila FI. Endosc Ultrasound 2013, Ishiwatari H. World J Gastroenterol 2014.</text>
		</slide>
		<slide index="13" title="Major complications of EUS-CPN" titleNormalized="major complications of eus-cpn" src="slide14.swf" size="100191" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="21.3609995"/>
			</animationSteps>
			<notes>However, major complications have rarely been reported using EUS-CPN. 
Most of them were reported in the setting of chronic pancreatitis.</notes>
			<notesNormalized>however, major complications have rarely been reported using eus-cpn. 
most of them were reported in the setting of chronic pancreatitis.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;However, major complications have rarely been reported using EUS-CPN. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Most of them were reported in the setting of chronic pancreatitis.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Major complications of EUS-CPN
14
Author
Complication
Indication
Technique
Substance
Fujii L 
(Endoscopy 2012)
Paraplegia
PC
CGN+CPN
Bupivacaine+Alcohol 1mL(CGN)+23mL(CPN)
Loeve US 
(GIE 2013)
Necrosis &amp; perforation of stomach &amp; aorta/ dead
CP
Multiple CPN
(13 sessions for 4 years)
Bupivacaine 6-10mL + Alcohol 8-20mL
Jang HY 
(Clin Endosc 2013)
Liver &amp; spleen infarction
Stomach &amp; small intestine ischemia/ dead
Lung ca.
Panc. meta
CPN(central)
Bupivacaine 5mL + Alcohol 10mL
+ Triamcinolone 1mL + Saline 3mL
*
* 
CA thrombosis + liver, lt-kidney, spleen, stomach, small intestine, and ascending colon infarction
(20mL)
(10mL)
Gimeno-Garcia AZ. Endoscopy 2012
Major complications have rarely been reported using EUS-CPN.
Most of bleeding complications occurred in the bilateral technique.
Most of infectious complications were reported in the setting of chronic pancreatitis.</text>
		</slide>
		<slide index="14" title="Adverse effects during and after the procedure" titleNormalized="adverse effects during and after the procedure" src="slide15.swf" size="3435" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.3689999"/>
			</animationSteps>
			<notes>This slide shows that there was no difference between the 2 groups in adverse events.
Adverse effects experienced by the patients are shown in this slide.</notes>
			<notesNormalized>this slide shows that there was no difference between the 2 groups in adverse events.
adverse effects experienced by the patients are shown in this slide.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;This slide shows that there was no difference between the 2 groups in adverse events.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Adverse effects experienced by the patients are shown in this slide.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>15
　
EUS-CGN (n = 34)
EUS-CPN (n = 33)
p Value
Transient hypotension
1 (2.9%)
2 (6.0%)
0.613
Upper gastrointestinal bleeding
1 (2.9%)
0 (0%)
1.000
Inebriation
1 (2.9%)
1 (3.0%)
1.000
Transient pain exacerbation
10 (30.3%)
7 (21.9%)
0.576
Transient diarrhea
2 (5.9%)
3 (9.1%)
0.673
Adverse effects during and after the procedure
Doi S, Yasuda I, et al. Endoscopy 2013</text>
		</slide>
		<slide index="15" title="Conclusions" titleNormalized="conclusions" src="slide16.swf" size="1935" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="22.0990004"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Conclusions
EUS-CGN is significantly superior to EUS-CPN in providing cancer pain relief.
16
EUS-CPN is a relatively safe and effective method to reduce upper abdominal cancer pain.
The actual techniques of EUS-CPN and EUS-CGN were shown.</text>
		</slide>
	</slides>
</presentation>
